Fibrinolytic Split Products, Fibrinolysis, and Factor XIII Activity in Inflammatory Bowel Disease

References

• Ormerod T. P. Anaemia in ulcerative colitis. Proc Royal Soc Med 1968; 61: 931–4
   PubMedGoogle Scholar
• Bargen J. A., Barker N. W. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936; 58: 17–31
   Google Scholar
• Lee JCL, Spittell J. A., Sauer W. G., Owen C. A., Thompson J. H. Hypercoagubility associated with chronic ulcerative colitis: changes in blood coagulation factors. Gastroenterology 1968; 54: 76–85
   PubMed Web of Science ®Google Scholar
• Lam A., Borda I. T., Inwood M. J., Thompson S. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 1975; 68: 245–51
   PubMed Web of Science ®Google Scholar
• Mori K., Watanabe H., Hiwatashi N., Sugai K., Goto Y. Studies on blood coagulation in ulcerative colitis and Crohn's disease. Tohoku J Exp Med 1980; 132: 93–101
   PubMed Web of Science ®Google Scholar
• Talbot R. W., Heppell J., Dozois R. R., Beart R. W. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61: 140–5
   PubMed Web of Science ®Google Scholar
• Chamouard P., Grunebaum L., Duclos B., Wiesel I., Cazenave J. P. Manifestations biologiques d'un état préthrombotique au cours de la maladie de Crohn évolutive. Gastroenterol Clin Biol 1990; 14: 961–6
   PubMedGoogle Scholar
• Gris J. C., Schved J. F., Raffanel C., Dubois A., Aguilar-Martinez P, Arnaud A, et al. Impaired fibrinolytic capacity in patients with inflammatory bowel disease. Thromb Haemost 1990; 63: 472–5
   PubMed Web of Science ®Google Scholar
• DeJong E, Porte R. J., Knot EAR, Verhcyen J. H., Dees J. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut 1989; 30: 188–94
   Google Scholar
• Galloway M. J., Mackie M. J., McVerry B. A. Reduced levels of factor XIII in patients with chronic inflammatory bowel disease. Clin Lab Haematol 1983; 5: 427–8
   PubMedGoogle Scholar
• Stadnicki A., Kloczko J., Nowak A., Sierka E. Alterations of haemostasis parameters with special reference to factor XIII and fibronectin in patients with ulcerative colitis. Eur J Gastroenterol Hepatol 1992; 4: 743–6
   Web of Science ®Google Scholar
• Tamaki T., Aoki N. Cross-linking of α2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochem Biophys Acta 1981; 661: 280–6
   PubMed Web of Science ®Google Scholar
• Mosher D. F. Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem 1975; 250: 6614–21
   PubMed Web of Science ®Google Scholar
• Bernstein C. N., Shahanan F. Factor XIII: is it a factor in Crohn's disease?. Gastroenterology 1993; 105: 605–7
   PubMedGoogle Scholar
• Chambless L. E., McMahon R, Wu K, Folsom A, Finch A, Shen Y-L. Short-term intraindividual variability in hemostasis factors. Ann Epidemiol 1992; 2: 723–33
   PubMedGoogle Scholar
• Wisén O, Gårdlund B. Hemostasis in Crohn's disease: low factor XIII levels in active disease. Scand J Gastroenterol 1988; 23: 961–6
   PubMed Web of Science ®Google Scholar
• Hudson M., Wakefield A. J., Hutton R. A., Sankey E. A., Dhillon A. P., More L., et al. Factor XIIIA subunit and Crohn's disease. Gut 1993; 34: 75–9
   PubMed Web of Science ®Google Scholar
• Suzuki R., Toda H., Takamura Y. Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate. Blut 1989; 59: 162–4
   PubMedGoogle Scholar
• Lorenz R., Clemens R., Karl M., Classen M. Substitution von F XIII-Konzentrat bei Colitis ulcerosa. Z Gastroenterol 1989; 27: 87–90
   PubMedGoogle Scholar
• Lennard-Jones J. E. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 24(Suppl 170)2–6
   Web of Science ®Google Scholar
• Riley S. A., Mani V., Goodman M. J., Herd M. E., Dutt S., Turnberg L. A. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. Gut 1988; 29: 669–74
   PubMed Web of Science ®Google Scholar
• Vander Heide H, Vander Brandt-Gradel V, Tytgat GNJ, Endert E, Wiltink EHH, Schipper MEI, et al. Comparison of beclomethasone diproprionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis. J Clin Gastroenterol 1988; 10: 169–72
   PubMed Web of Science ®Google Scholar
• VanHees PAM, VanElteren P. H., VanLier HJJ, VanTongeren JHM. An index of inflammatory activity in patients with Crohn's disease. Gut 1980; 21: 279–86
   PubMed Web of Science ®Google Scholar
• Thompson W. G., Dotevall G., Drossman D. A., Heaton K. W., Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterology Int 1989; 2: 92–5
   Google Scholar
• Edwards R. L., Levine J. B., Green R., Duffy M., Mathews E., Brande W., et al. Activation of blood coagulation in Crohn's disease. Gastroenterology 1987; 92: 329–37
   PubMed Web of Science ®Google Scholar
• Conlan M. G., Williams D. H., Burnett D. A. Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1089–93
   PubMed Web of Science ®Google Scholar
• Kurose I., Miura S., Suematsu M., Serizawa H., Fukumura D., Asako H., et al. Tissue-type plasminogen activator of colonic mucosa in ulcerative colitis. Dig Dis Sci 1992; 37: 307–11
   PubMed Web of Science ®Google Scholar
• Castell J. V., Andus T., Kunz D., Heinrich P. C. Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat. Ann NY Acad Sci 1989; 557: 87–101
   PubMed Web of Science ®Google Scholar
• Gauldie J., Richards C., Northemann W., Fey G., Baumann H. IFN beta2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor specific acute phase gene regulation in hepatocytes. Ann NY Acad Sci 1989; 557: 46–59
   PubMed Web of Science ®Google Scholar
• James S. P. The role of lymphokines and cytokines in mucosal immune function. Curr Opin Gastroenterol 1991; 7: 437–45
   Web of Science ®Google Scholar
• Sakata Y., Aoki N. Cross-linking of α2-plasmin inhibitor to fibrin by fibrin stabilizing factor. J Clin Invest 1980; 65: 290–7
   PubMed Web of Science ®Google Scholar
• Duckert F. Documentation of the plasma factor XIII deficiency in man. Ann NY Acad Sci 1972; 202: 190–9
   PubMed Web of Science ®Google Scholar
• Hollanders D., Thomson J. M., Schofield P. F. Tranexamic acid therapy in ulcerative colitis. Postgrad Med J 1982; 58: 87–91
   PubMed Web of Science ®Google Scholar